This Is MS Multiple Sclerosis Knowledge & Support Community

Glatiramer acetate treatment effects on gene expression in monocytes of MS patients

Glatiramer acetate (GA) is a mixture of synthetic peptides used in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to investigate the effects of GA therapy on the gene expression of monocytes........ Read More - http://www.ms-uk.org/copaxone